ConductScience.org, home

Paper368243

Idiopathic paraproteinemia. II. Transplantation of the paraprotein-producing clone from old to young C57BL/KaLwRij mice.

Radl J and 3 others. J Immunol, 1979. Cited by 147 papers, by iCite.

Cite this record

ConductScience Library. Idiopathic paraproteinemia. II. Transplantation of the paraprotein-producing clone from old to young C57BL/KaLwRij mice. Papers, record 368243. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/368243

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Idiopathic paraproteinemia. II. Transplantation of the paraprotein-producing clone from old to young C57BL/KaLwRij mice.
PubMed
Journal
J Immunol
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
147
iCite
Relative citation ratio, by iCite
2.79
iCite
Revised in PubMed
2003-11-14
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Radl JJ
2De Glopper EDE D
3Schuit HRH R
4Zurcher CC

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AgingMajor topic
ParaproteinemiasMajor topic
ParaproteinsMajor topic
Animals
Bone Marrow
Clone Cells
Fluorescent Antibody Technique
Male
Mice
Mice, Inbred C57BL
Spleen
Transplantation, Homologous

Source PubMed

Download CSV of topics

Cited by77

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 147 citations.

PMIDTitleJournalYearIn PapersSource
41791669Engineering bone marrow in a dish-a bloody business: preclinical opportunities, translational use cases, and a call for consensus.J Thromb Haemost2026https://conductscience.org/library/papers/41791669PubMed
41627211Endogenous CD28 Drives the Persistent Activity of CAR T Cells in Myeloma and Lymphoma Models.Blood Cancer Discov2026https://conductscience.org/library/papers/41627211PubMed
41188965Human preclinical multiple myeloma in vitro models for disease modeling and therapy screening.J Biol Eng2025https://conductscience.org/library/papers/41188965PubMed
39695697Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma.J Hematol Oncol2024https://conductscience.org/library/papers/39695697PubMed
39353958DNA vaccines against GPRC5D synergize with PD-1 blockade to treat multiple myeloma.NPJ Vaccines2024https://conductscience.org/library/papers/39353958PubMed
38562904Endogenous CD28 drives CAR T cell responses in multiple myeloma.bioRxiv2024https://conductscience.org/library/papers/38562904PubMed
37629558Current and Future PET Imaging for Multiple Myeloma.Life (Basel)2023https://conductscience.org/library/papers/37629558PubMed
37173940The Synthetic Collagen-Binding Peptide NIPEP-OSS Delays Mouse Myeloma Progression.Cancers (Basel)2023https://conductscience.org/library/papers/37173940PubMed
37031341Molecular characterization stratifies VQ myeloma cells into two clusters with distinct risk signatures and drug responses.Oncogene2023https://conductscience.org/library/papers/37031341PubMed
34503090An Improved Animal Model of Multiple Myeloma Bone Disease.Cancers (Basel)2021https://conductscience.org/library/papers/34503090PubMed
34163520Animal Models of Multiple Myeloma Bone Disease.Front Genet2021https://conductscience.org/library/papers/34163520PubMed
34149703Laboratory Mice - A Driving Force in Immunopathology and Immunotherapy Studies of Human Multiple Myeloma.Front Immunol2021https://conductscience.org/library/papers/34149703PubMed
33579905A distinct metabolic response characterizes sensitivity to EZH2 inhibition in multiple myeloma.Cell Death Dis2021https://conductscience.org/library/papers/33579905PubMed
33374627Current Understanding of Myelomatous Mesenchymal Stromal Cells Extended through Advances in Experimental Methods.Cancers (Basel)2020https://conductscience.org/library/papers/33374627PubMed
32923989Characterization of the role of Samsn1 loss in multiple myeloma development.FASEB Bioadv2020https://conductscience.org/library/papers/32923989PubMed
32083236Differential Pain-Related Behaviors and Bone Disease in Immunocompetent Mouse Models of Myeloma.JBMR Plus2020https://conductscience.org/library/papers/32083236PubMed
31995627GLIPR1 expression is reduced in multiple myeloma but is not a tumour suppressor in mice.PLoS One2020https://conductscience.org/library/papers/31995627PubMed
31886918Myeloma Cells Down-Regulate Adiponectin in Bone Marrow Adipocytes Via TNF-Alpha.J Bone Miner Res2020https://conductscience.org/library/papers/31886918PubMed
31475039The Use of Murine Models for Studying Mechanistic Insights of Genomic Instability in Multiple Myeloma.Front Genet2019https://conductscience.org/library/papers/31475039PubMed
30874356Plasma cells: You are what you eat.Immunol Rev2019https://conductscience.org/library/papers/30874356PubMed

See all 77 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/368243

GET https://conductscience.org/api/papers/v1/368243/cited_by?page=2